RNAi therapeutics company Alnylam Pharmaceuticals Inc reported positive interim data from its ongoing Phase 1 study of ALN-AGT. The company is evaluating ALN-AGT …
Markets are plunging, taking a serious hit as the coronavirus spreads rapidly throughout the world. So far, the worst of the outbreak is …
Analyst praises Alnylam’s patisiran as best-in-class, even more confident in its safety and tolerability profile.
Tesla Motors Inc Tesla Motors Inc (NASDAQ:TSLA) shares dropped nearly 4% today after Goldman Sachs analyst David Tamberrino downgraded the electric car giant from Buy to …
Analysts offer insights into a volatile biotech-verse amid Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) shares dipping on news of a program termination and Aurinia Pharmaceuticals (NASDAQ:AUPH) soaring on …
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) investors are having a rough morning after the RNAi therapeutics company announced that it has decided to discontinue development of revusiran, an …